Carmen
De Mendoza Fernandez
Forscherin in der Zeit 2019-2022
Hospital San Pedro
Logroño, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital San Pedro (7)
2015
-
Liver fibrosis progression despite HCV cure with antiviral therapy in HIV-HCV-coinfected patients
Antiviral Therapy, Vol. 20, Núm. 3, pp. 329-334
-
Transmitted drug resistance to rilpivirine in newly diagnosed antiretroviral naive adults
Clinical Microbiology and Infection, Vol. 21, Núm. 1, pp. 104.e1-104.e5
-
Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007-2012)
Clinical Microbiology and Infection, Vol. 21, Núm. 1, pp. 105.e1-105.e5
2014
-
Changes in liver fibrosis in HIV/HCV-coinfected patients following different outcomes with peginterferon plus ribavirin therapy
Journal of Viral Hepatitis, Vol. 21, Núm. 7, pp. 475-479
-
Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries
AIDS, Vol. 28, Núm. 16, pp. 2461-2473
2003
-
Long-term outcome of HIV-infected patients with multinucleoside-resistant genotypes
HIV Clinical Trials, Vol. 4, Núm. 6, pp. 372-381
2002
-
Impact of HIV genotyping and drug levels on the response to salvage therapy with saquinavir/ritonavir
AIDS, Vol. 16, Núm. 14, pp. 1964-1966